NCT06392945 Effects of Rhythmic Auditory Cueing Augments Cognitive Treadmill Walking Training in Individuals With Chronic Stroke
| NCT ID | NCT06392945 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-05-24 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-05-24 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The first objective of this study is to examine the superiority of the combined rhythmic auditory cueing with cognitive treadmill training (combined group) in people with stroke as compared with the cognitive treadmill walking training (cognitive group) or treadmill walking training alone (treadmill group) (Aim 1). The study's second aim is to investigate the factors affecting the improvement in community walking capacity after interventions and to explore whether changes in community walking capacity are associated with changes in participation after interventions (Aim 2).
Eligibility Criteria
Inclusion Criteria: * diagnosed with first-time stroke; * more than 6 months after stroke onset; * able to walk 10 meters; * no severe vision, hearing, or speech impairments; * understand and follow the instructions and sign the Informed Consent Form; * older than 20 years old. Exclusion Criteria: * orthopedic problems affecting walking or other diseases that may interfere with study participation; * a score of less than 24 on the mini-mental state examination (MMSE); * severe balance disorder with a total score of less than 45 points Berg Balance Scale.
Contact & Investigator
Li-Ling Chuang, Ph.D.
PRINCIPAL INVESTIGATOR
Chang Gung University
Frequently Asked Questions
Who can join the NCT06392945 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06392945 currently recruiting?
Yes, NCT06392945 is actively recruiting participants. Contact the research team at lchunag@gap.cgu.edu.tw for enrollment information.
Where is the NCT06392945 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06392945 clinical trial?
NCT06392945 is sponsored by Chang Gung University. The principal investigator is Li-Ling Chuang, Ph.D. at Chang Gung University. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.